This randomized controlled trial investigated the effects of oral glutamine supplementation in preventing oxaliplatin-induced peripheral neuropathy among 86 metastatic colorectal cancer patients. Participants receiving glutamine (15 g twice daily for seven days every two weeks) experienced significantly lower rates of grade 3–4 neuropathy after four and six cycles (4.8% vs.
